Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Beijing Tong Ren Tang Chinese Medicine Co ( (HK:3613) ).
Beijing Tong Ren Tang Chinese Medicine Co announced a postponement and rescheduling of its annual general meeting, which is set to approve a final dividend of HKD 0.35 per share for the year ended December 31, 2024. This update affects the book closure dates for determining dividend entitlement, with the new record date set for June 11, 2025, and payment scheduled for June 18, 2025. This announcement may impact shareholder expectations and the company’s financial planning.
More about Beijing Tong Ren Tang Chinese Medicine Co
Beijing Tong Ren Tang Chinese Medicine Co is a company operating in the traditional Chinese medicine industry, focusing on the production and distribution of herbal medicines and related health products. The company is known for its extensive range of traditional remedies and has a significant market presence in Hong Kong and other regions.
YTD Price Performance: -0.31%
Technical Sentiment Signal: Buy
Current Market Cap: $920.4M
See more data about 3613 stock on TipRanks’ Stock Analysis page.